RMTI Rockwell Medical, Inc.

8.62
0  0%
Previous Close 8.64
Open 8.63
Price To book 8.40
Market Cap 444.16M
Shares 51,527,000
Volume 293,011
Short Ratio 38.70
Av. Daily Volume 305,685

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approved January 26, 2015.
Soluble Ferric Pyrophosphate
Iron deficiency

Latest News

  1. Rockwell Medical Announces Poster Presentation and Oral Presentation on Triferic at the 7th Congress of the International BioIron Society May 7 – 11, 2017
  2. Richmond Brothers and Mark H. Ravich Send Letter to Rockwell Medical, Inc. Shareholders
  3. Rockwell Medical Files Definitive Proxy Materials
  4. Rockwell Medical (RMTI) Catches Eye: Stock Moves Up 12.1%
  5. Rockwell Medical (RMTI) Looks Good: Stock Moves 5.9% Higher
  6. Rockwell Medical Announces Triferic® Poster Presentations at the National Kidney Foundation (NKF) Spring Clinical Meeting in Orlando, FL April 18-22, 2017
  7. Richmond Brothers and Mark Ravich File Preliminary Proxy on Rockwell Medical, Inc.
  8. Rockwell Medical Files Preliminary Proxy Statement for Annual Meeting
  9. Rockwell Medical Announces ESA Sparing, Compositions and Use Patent Allowed in China
  10. ETFs with exposure to Rockwell Medical, Inc. : March 27, 2017
  11. Richmond Brothers and Mark Ravich Comment on Rockwell Medical, Inc. Lawsuit
  12. Rockwell Medical, Inc. :RMTI-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
  13. Rockwell Medical, Inc. breached its 50 day moving average in a Bullish Manner : RMTI-US : March 17, 2017
  14. Richmond Brothers and Mark Ravich Comment on Rockwell Medical, Inc. Earnings
  15. Edited Transcript of RMTI earnings conference call or presentation 15-Mar-17 8:30pm GMT
  16. Rockwell Medical reports 4Q loss
  17. Rockwell Medical Reports Fourth Quarter Results
  18. Rockwell Medical Schedules Fourth Quarter & Year End 2016 Earnings Call
  19. Richmond Brothers and Mark Ravich Respond to Rockwell Medical, Inc. Lawsuit
  20. Rockwell Medical Announces One Poster and Two Oral Presentations on Triferic at Annual Dialysis Conference March 11th-14th in Long Beach, CA